CHOOLIP & SCIENCES Inc. (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 1,683.00
-72.00 (-4.10%)
At close: Sep 3, 2026
CHOOLIP & SCIENCES Market Cap
CHOOLIP & SCIENCES has a market cap or net worth of 50.51 billion as of September 4, 2026. Its market cap has increased by 39.68% in one year.
Market Cap
50.51B
Enterprise Value
45.88B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,683.00
ChartMarket Cap Chart
Since September 16, 2020, CHOOLIP & SCIENCES's market cap has decreased from 234.93B to 50.51B, a decrease of -78.50%. That is a compound annual growth rate of -22.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 50.51B | 65.53% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PanGen Biotech | 67.50B |
| Psomagen | 66.17B |
| NovMetaPharma | 64.02B |
| ABION | 60.91B |
| TegoScience | 60.69B |
| KoBioLabs | 56.51B |
| QuadMedicine | 56.20B |
| J2KBIO | 55.20B |